Celularity Inc. CELU
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.78% | -58.43% | -130.08% | 34.71% | 63.94% |
| Total Depreciation and Amortization | -32.28% | -32.04% | -12.29% | -15.39% | -16.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 115.56% | 85.33% | -4.26% | -77.88% | -89.70% |
| Change in Net Operating Assets | -9.66% | 50.78% | 291.77% | 244.37% | 207.32% |
| Cash from Operations | -76.60% | -107.06% | 46.85% | 87.61% | 82.23% |
| Capital Expenditure | -- | -- | 86.00% | 89.64% | 86.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -100.00% | -- |
| Cash from Investing | -- | -- | -204.33% | -222.67% | 162.98% |
| Total Debt Issued | 2,572.81% | 364.16% | -52.73% | -96.45% | -96.45% |
| Total Debt Repaid | -7,215.17% | 65.63% | 65.37% | 99.30% | 99.45% |
| Issuance of Common Stock | 27.76% | -73.32% | -73.32% | -84.23% | -93.55% |
| Repurchase of Common Stock | 85.18% | 84.90% | 33.04% | 32.90% | 33.01% |
| Issuance of Preferred Stock | -66.67% | -66.67% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -78.78% | -76.74% | -11.60% | -25.68% | -41.84% |
| Cash from Financing | 221.65% | 178.30% | 33.55% | -61.94% | -84.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.52% | 562.78% | 98.41% | 105.19% | 85.59% |